First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer
SUZHOU, China, Feb. 27, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-301) of anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003. The study aims to compare the efficacy and safety of JSKN003...
The debate on MSCs is over; it’s time to promote MSC therapy in practice
TIANJIN, China, Feb. 27, 2025 /PRNewswire/ -- The debate on MSCs, mesenchymal stromal cells versus mesenchymal stem cells, continued for more than two decades (since 2006), being the major obstacle for MSCs study and clinical application. The major issue focuses on mesenchymal stem cells could not be approved for clinical application without a thorough test for safety issue (e.g....
AIM Vaccine’s mRNA RSV Vaccine Approved for U.S. Clinical Trials
Innovation and Global Expansion Attract Capital Reassessment AIM Vaccine Co., Ltd.(a joint stock company incorporated in the People's Republic of China with limited liability)(Stock Code: 6660.HK) HONG KONG, Feb. 27, 2025 /PRNewswire/ -- The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical sector, PRC vaccine leader...
ZEISS VISUMAX 800 with SMILE pro software receives approval in China
Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow JENA, Germany and SHANGHAI, Feb. 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the National Medical Products Administration (NMPA) in China has approved the VISUMAX® 800 with SMILE® pro software from ZEISS for...
McCrae Hospitals and Orion Health expand Viet Nam footprint through key partnerships
AUCKLAND, New Zealand, Feb. 27, 2025 /PRNewswire/ -- A signing ceremony with New Zealand Prime Minister Christopher Luxon and Franco-Vietnamese (FV) Hospital Group in Ho Chi Minh City, Viet Nam yesterday marked the first milestone in preparation for the launch of ambitious Kiwi health tech innovation firm McCrae Hospitals, as well as Orion Health's ongoing commitment to the region. ...
Perennial Tianjin Medical Cluster, Including China’s First Wholly Foreign-Owned Private Tertiary General Hospital, Officially Opened
Separate MOUs signed with SingHealth for bilateral cross-border knowledge exchange, and with Tianjin Academy of TCM for expansion into Singapore SINGAPORE, Feb. 26, 2025 /PRNewswire/ -- Perennial Holdings Private Limited ("Perennial Holdings") marked a major milestone today with the official opening of the medical cluster, comprising three hospitals with a total of 1,000...
Lunit Announces Leadership Transition at Volpara: Craig Hadfield Appointed CEO
SEOUL, South Korea and WELLINGTON, New Zealand, Feb. 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the appointment of Craig Hadfield as the new CEO of its subsidiary, Volpara Health Technologies. Craig, who currently serves as Volpara's Chief Customer and Financial...
Visionary Holdings: Deeply Responding to the Concerns of the Capital Market and Demonstrating Solid Development Strength
TORONTO, Feb. 26, 2025 /PRNewswire/ -- Recently, in response to numerous questions from the capital market regarding Visionary Holdings (Nasdaq Stock Code: GV), the company has specifically issued this press release with the aim of providing a comprehensive and clear response to these concerns and showcasing the company's stable development trend and broad prospects. The company has always...
Neurophet Presented Three Research Abstracts on Personalized tDCS at International Brain Stimulation Conference
- Showcased core technology and products for personalized tDCS at the conference in Kobe, Japan - Presented clinical outcomes in disorders of consciousness, upper extremity function in patients with sub-acute and chronic stroke, and post-stroke dysphagia SEOUL, South Korea, Feb. 26, 2025 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim),...
Venus Williams Invests in WeWard App to Promote a Healthier World Through Walking
Tennis champion and entrepreneur Venus Williams joins walking app WeWard as an investor and ambassador. NEW YORK, Feb. 26, 2025 /PRNewswire/ -- WeWard, the free walking app that rewards 20M users for every step, today announced that tennis champion and entrepreneur Venus Williams has joined the company as both an investor and ambassador. This...
